- Home
- TISI vs VTVT Comparison
TISI vs VTVT Comparison
Compare TISI & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TISI
- VTVT
- Stock Information
- Founded
- TISI 1973
- VTVT 2015
- Country
- TISI United States
- VTVT United States
- Employees
- TISI N/A
- VTVT N/A
- Industry
- TISI Other Consumer Services
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- TISI Consumer Discretionary
- VTVT Health Care
- Exchange
- TISI Nasdaq
- VTVT Nasdaq
- Market Cap
- TISI 66.4M
- VTVT 54.4M
- IPO Year
- TISI N/A
- VTVT 2015
- Fundamental
- Price
- TISI $16.95
- VTVT $31.15
- Analyst Decision
- TISI
- VTVT Strong Buy
- Analyst Count
- TISI 0
- VTVT 2
- Target Price
- TISI N/A
- VTVT $35.50
- AVG Volume (30 Days)
- TISI 20.2K
- VTVT 5.3K
- Earning Date
- TISI 11-12-2025
- VTVT 11-06-2025
- Dividend Yield
- TISI N/A
- VTVT N/A
- EPS Growth
- TISI N/A
- VTVT N/A
- EPS
- TISI N/A
- VTVT N/A
- Revenue
- TISI $870,735,000.00
- VTVT $17,000.00
- Revenue This Year
- TISI N/A
- VTVT N/A
- Revenue Next Year
- TISI N/A
- VTVT N/A
- P/E Ratio
- TISI N/A
- VTVT N/A
- Revenue Growth
- TISI 2.55
- VTVT N/A
- 52 Week Low
- TISI $11.12
- VTVT $12.62
- 52 Week High
- TISI $24.25
- VTVT $33.06
- Technical
- Relative Strength Index (RSI)
- TISI 60.83
- VTVT 85.36
- Support Level
- TISI $15.35
- VTVT $24.31
- Resistance Level
- TISI $16.85
- VTVT $33.06
- Average True Range (ATR)
- TISI 0.99
- VTVT 2.03
- MACD
- TISI 0.27
- VTVT 0.91
- Stochastic Oscillator
- TISI 99.17
- VTVT 88.15
About TISI Team Inc.
Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin, being investigated for the treatment of type 1 diabetes (T1D). Its product pipeline includes TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.